Testing Ashkenazi Jewish Women for Mutations Predisposing to Breast Cancer in Genes Other Than BRCA1 and BRCA2. - Suppr | 超能文献

Testing Ashkenazi Jewish Women for Mutations Predisposing to Breast Cancer in Genes Other Than BRCA1 and BRCA2.

作者信息

Narod Steven, Sopik Victoria, Cybulski Cezary

机构信息

Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.

出版信息

JAMA Oncol. 2018 Jul 1;4(7):1012. doi: 10.1001/jamaoncol.2018.0595.

DOI:10.1001/jamaoncol.2018.0595

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Testing Ashkenazi Jewish Women for Mutations Predisposing to Breast Cancer in Genes Other Than BRCA1 and BRCA2.

JAMA Oncol. 2018 Jul 1;4(7):1012. doi: 10.1001/jamaoncol.2018.0595.

2

Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.非 BRCA1 和 BRCA2 种系突变导致的阿什肯纳兹犹太裔妇女乳腺癌遗传易感性。

JAMA Oncol. 2017 Dec 1;3(12):1647-1653. doi: 10.1001/jamaoncol.2017.1996.

3

Testing Ashkenazi Jewish Women for Mutations Predisposing to Breast Cancer in Genes Other Than BRCA1 and BRCA2-Reply.

JAMA Oncol. 2018 Jul 1;4(7):1012-1013. doi: 10.1001/jamaoncol.2018.0616.

4

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.携带BRCA1和BRCA2突变的阿什肯纳兹犹太女性患卵巢癌的风险。

Clin Cancer Res. 2002 Dec;8(12):3776-81.

5

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.阿什肯纳兹犹太裔患者中BRCA1和BRCA2非始祖突变的发生率。

Breast Cancer Res Treat. 2015 Jan;149(1):223-7. doi: 10.1007/s10549-014-3218-x. Epub 2014 Dec 6.

6

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.阿什肯纳兹犹太人群中BRCA1和BRCA2常见突变的频率。

Nat Genet. 1996 Oct;14(2):185-7. doi: 10.1038/ng1096-185.

7

[Search for frequently encountered mutations in genes predisposing to breast cancer].

Genetika. 2001 Dec;37(12):1681-6.

8

MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.MDM2基因单核苷酸多态性309加速了犹太裔阿什肯纳兹血统的BRCA1和BRCA2携带者的乳腺癌和卵巢癌发生。

Breast Cancer Res Treat. 2008 Oct;111(3):497-504. doi: 10.1007/s10549-007-9797-z. Epub 2007 Nov 18.

9

Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.在阿什肯纳兹族乳腺癌和卵巢癌家族中未发现基因组 BRCA1 和 BRCA2 重排。

Breast Cancer Res Treat. 2010 Sep;123(2):581-5. doi: 10.1007/s10549-010-0818-y. Epub 2010 Mar 11.

10

BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer.患有乳腺癌和卵巢癌的德系犹太家族中的BRCA1和BRCA2基因突变。

Genet Test. 1997;1(1):41-6. doi: 10.1089/gte.1997.1.41.

引用本文的文献

1

How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?法律和政策如何促进临床护理中基因组分析和解释的质量？

J Law Med Ethics. 2020 Mar;48(1):44-68. doi: 10.1177/1073110520916995.

2

Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer.乳腺癌诊断后生殖系基因检测类型及结果与患者癌症担忧的关联

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00225. Epub 2018 Dec 19.